2019
DOI: 10.1016/j.ejso.2018.12.020
|View full text |Cite
|
Sign up to set email alerts
|

An analysis of the morbidity associated with abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 33 publications
0
12
0
Order By: Relevance
“…Our search yielded ninety four articles of which nine studies were selected for data extraction [ 10 , 19 21 , 32 34 , 44 ]. Studies selected were published between 2014 and 2023, conducted in six countries.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Our search yielded ninety four articles of which nine studies were selected for data extraction [ 10 , 19 21 , 32 34 , 44 ]. Studies selected were published between 2014 and 2023, conducted in six countries.…”
Section: Resultsmentioning
confidence: 99%
“…All but one study took place at a single institution [ 33 ]. One study did not specify its location but collected data from a prospectively maintained database [ 32 ]. Eight studies included patients who underwent both CRS and HIPEC.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…4,5 Today, this treatment is successfully used in the treatment modality of colo-rectal, appendix, ovarian, mesothelioma, and gastric cancers. [6][7][8][9] Th e purpose of CRS and HIPEC treatment is to remove the tumors in the intra-abdominal organs and peritoneum (Complete cytoreduction) and then to give heated chemotherapy into the abdomen. 4,9,10 In this treatment, multiple organ resections may be required due to the involvement of the organs with the tumor.…”
Section: Introductionmentioning
confidence: 99%